News | September 17, 2009

Inflation Rates for Healthcare Supplies Steady in 2010, Isotope Prices to Fluctuate

September 17, 2009 - Inflation rates for healthcare supplies are projected to remain unchanged through 2010, according to an analysis released by the Premier healthcare alliance.

Premier’s Economic Outlook and Inflation Estimates analysis through 2010 suggests annual market inflation rates will increase on average between 1.6 percent and 4 percent across categories such as cardiovascular services, facilities, imaging and nursing. These predicted market price increases are similar to those projected by Premier in its March 2009 analysis and suggest that incremental inflationary factors are waning.

The Economic Outlook is a semiannual report that projects rates of inflation for the ensuing 12-18 months. Premier produces a new analysis every six months to ensure projections are reflective of changing market trends. The analysis helps alert Premier alliance hospital members to market forces that could drive price changes in the coming months and years.

According to the analysis, the healthcare industry may see pricing changes related to the following factors:
· Isotope shortages – Continued price increases are expected in this area, which has experienced increases by double digits over the past 18 months due to limited production capacity worldwide; only five nuclear reactors on the planet are capable of producing the needed isotopes, which are used in nuclear imaging.
· New technology expenses – Products such as radio frequency identification (RFID – used to track items in case of a recall) enabled sponges and pacemakers with capabilities in place for home checkups will increase initial medical equipment expenses for hospitals, but will result in tremendous savings over the life of the products.
· Pharmaceuticals – As generic versions of key drugs infiltrate the market in the coming months (at least 18 key pharmaceutical products are expected to have their exclusivity rights expire before the end of 2009), expect costs for these drugs to decrease.
· Synthetic rubber prices – As the cost of rubber (both synthetic and natural) begins to increase to reflect the resurgent demand, healthcare professionals could see an increase in all products containing rubber, such as gloves, airway tubes, stomach tubes, rubber sheeting, irrigating syringes and water bottles.
· Pandemic disaster preparation techniques – Items such as gloves, face masks and gowns are in high demand as providers prepare for an influx of H1N1 influenza cases this fall; higher inventory levels may be required to support disaster readiness plans.
· Oil prices and distribution costs – Price increases are expected in medical materials such as bandages, syringes, vinyl gloves, catheters and medical film that contain synthetic rubber, plastics, resins and other oil-based materials. The market prices of these materials will naturally fluctuate with the cost of oil.

For more information: www.premierinc.com

Related Content

PET/CT Changes Care for 59 Percent of Suspected Recurrent Prostate Cancer Cases
News | Prostate Cancer | June 13, 2018
A recently presented investigational clinical trial evaluated the impact of 18F fluciclovine positron emission...
Nuclear imaging scan showing very good tissue delineation. Scan performed on a Biograph Vision positron emission tomography/computed tomography (PET-CT) system from Siemens Healthineers.

Nuclear imaging scan showing very good tissue delineation. It offers crisp overall image quality and sharply delineates the muscle and fat planes, vertebral margins and end plates, billiary radicals, renal calyces, aortic wall and papillary muscles of the heart. Scan performed on a Biograph Vision positron emission tomography/computed tomography (PET-CT) system from Siemens Healthineers.

Technology | PET-CT | June 05, 2018
June 5, 2018 — The U.S.
PET Imaging Agent Could Provide Early Diagnosis of Rheumatoid Arthritis

Coronal 18F-FEDAC PET/CT section of a mouse with collagen-induced arthritis. (A) On day 23 and day 37, increased uptake is noted in the front and hind paws of this mouse with collagen-induced arthritis. (B) Predictive performance of day 23 18F-FEDAC uptake for the development of clinical arthritis. ROC = receiver operating characteristic; Sn = sensitivity; Sp = specificity. Credit: Seoul National University and Ewha Womans University, Seoul, South Korea

News | PET Imaging | May 17, 2018
A novel positron emission tomography (PET) tracer developed by Korean researchers can visualize joint inflammation and...
News | Radiopharmaceuticals and Tracers | May 09, 2018
Blue Earth Diagnostics signed an exclusive, worldwide agreement with Scintomics GmbH, Germany, a specialist in...
Cardiac MRI being performed at the DeBakey Heart Hospital.

Cardiac MRI being performed at the DeBakey Heart Hospital.

Feature | Cardiac Imaging | May 03, 2018 | By Jeff Zagoudis
Magnetic resonance imaging (MRI) for cardiac assessment provides a radiation-free alternative to other commonly used...
Novel PET Agent Could Help Guide Therapy for Brain Diseases

Rat brain 11C‐Me‐NB1 PET images (0‐60 min) superimposed on an MRI template. Credit: SD Krämer et al., ETH Zurich, Zurich, Switzerland

News | PET Imaging | April 10, 2018
Researchers have developed a new imaging agent that could help guide and assess treatments for people with various...
The Chalk River nuclear reactor license has been renewed, but will be decommissioned by 2028.

The Chalk River nuclear isotope reactor license has been renewed, but will be decommissioned by 2028. The reactor supplies about 50 percent of the world's supply of Tc99m.

Feature | Nuclear Imaging | April 02, 2018 | Dave Fornell
April 2, 2018 – The Canadian Nuclear Safety Commission (CNSC) announced March 29 that it renewed Canadian Nuclear Lab
Axumin PET Agent Added to NCCN Guidelines for Suspected Recurrent Prostate Cancer
News | PET Imaging | February 21, 2018
Blue Earth Diagnostics announced that Axumin (fluciclovine F 18) injection has been added to the National Comprehensive...
A Tc99m SPECT cardiac exam showing myocardial perfusion in the heart.

Technetium-99m is primarily used for the detection of cancer and to assess perfusion defects in the heart caused by heart attacks or other conditions.

Feature | Radiopharmaceuticals and Tracers | February 08, 2018 | Dave Fornell
February 8, 2018 — The U.S.
Overlay Init